ADVERTISEMENT

Leadership

Execs On The Move: December 8–12, 2025

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

New CEO Sonig Leads Rosemont Towards US Ambitions

UK liquids specialist Rosemont Pharmaceuticals has named industry veteran Alok Sonig as its new CEO, as the firm continues to set its sights on the US market. Meanwhile, Rosemont has also appointed Gavin Wood as chief financial officer.

Hikma Signals Reset With Abrupt CEO Change As Injectables Margins Slide

Hikma has initiated a leadership transition, with CEO Riad Mishlawi stepping down after just two years in the role, as margin pressure in its core Injectables business and operational delays weigh on performance.

Biogen Doubles Down On Immunology As Lupus Programs Near Readouts

With two late-stage lupus assets finishing recruitment and a newly acquired nephrology franchise running three concurrent Phase III programs, Biogen is making its most significant commitment yet to immunology beyond its legacy MS business.

Execs On The Move: December 1–5, 2025

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Execs On The Move: November 2025

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

AAM Urges ‘Steady Leadership’ At FDA Following Pazdur’s Abrupt Resignation

With Richard Pazdur’s abrupt exit marking the fifth CDER leadership change in a year, the AAM is urging continuity and stability amid the ongoing turbulence.

Execs On The Move: November 24–28, 2025

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

In Latest US FDA Drug Center Change, Lead In OTC Monograph, Switch Program Overhauls Out

FDA says Teresa Michele, in CDER nonprescription drugs program leadership roles since 2013, was being moved to another position in the agency.

Compugen’s Former Head Reflects on Computational Discovery, Strategic Collaborations And AI

Anat Cohen-Dayag explains how Compugen transformed from computational service provider to clinical-stage biotech by integrating AI with biology and structuring strategic pharma collaborations.

Who’s Hired? Alvotech Promotes McClellan To COO

As Alvotech continues to reorganize its senior team with the promotion of chief scientific officer Joseph McClellan to chief operating officer, multiple other firms – including Hikma, Hyloris, CNX and Cingulate – have also announced executive updates.

Execs On The Move: November 10–14, 2025

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.